XML 21 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
OPERATING ACTIVITIES      
Net income $ 513.4 $ 388.6 $ 460.2
Adjustments to reconcile net income to net cash provided by operating activities:      
Costs related to refinancing 0.0 15.1 0.0
Share-based compensation expense 40.6 57.9 38.4
Depreciation 62.9 62.2 55.9
Amortization 30.9 32.5 33.4
Deferred taxes 22.5 (11.1) (33.3)
Gain on sale of unconsolidated affiliate 0.0 0.0 (262.6)
Other, net (13.4) 4.2 5.9
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable 15.5 (188.1) 0.6
Inventories (496.5) (80.6) (65.0)
Prepaid and other assets (76.5) (19.4) (11.0)
Accounts payable 202.5 172.2 54.3
Other current liabilities (19.6) 154.6 49.7
Restructuring and other (2.0) (6.0) (100.2)
Other non-current items (10.1) (24.8) (0.3)
Other, net 1.3 0.7 0.8
Net cash provided by operating activities 271.5 558.0 226.8
INVESTING ACTIVITIES      
Proceeds from sale of long-lived assets 0.2 0.4 2.1
Investments in property, plant and equipment (106.9) (62.7) (42.4)
(Investments in) proceeds from loans receivable 0.0 (3.4) 20.8
Proceeds from sale of brand extension assets 0.0 115.5 0.0
(Investments in) proceeds from sale of unconsolidated affiliates (102.3)    
(Investments in) proceeds from sale of unconsolidated affiliates   0.0 274.3
Payment for acquisitions, net of cash acquired (127.8) 0.0 (6.6)
Purchase of convertible debt investments (193.1) 0.0 0.0
Other investing, net (8.7) (2.9) 7.0
Net cash (used in) provided by investing activities (538.6) 46.9 255.2
FINANCING ACTIVITIES      
Borrowings under revolving and bank lines of credit and term loans 1,243.2 1,222.7 1,056.2
Repayments under revolving and bank lines of credit and term loans (1,361.5) (1,413.8) (1,445.5)
Financing and issuance fees (13.1) (18.7) (0.2)
Dividends paid (143.0) (411.2) (124.5)
Purchase of Common Shares (129.3) (53.2) (3.1)
Payments on seller notes 0.0 (0.5) (0.8)
Cash received from exercise of stock options 15.2 17.6 21.4
Acquisition of noncontrolling interests (17.5) 0.0 0.0
Net cash provided by (used in) financing activities 494.0 (607.1) (496.5)
Effect of exchange rate changes on cash 0.6 0.0 (0.6)
Net increase (decrease) in cash and cash equivalents 227.5 (2.2) (15.1)
Cash and cash equivalents at beginning of year 16.6 18.8 33.9
Cash and cash equivalents at end of year 244.1 16.6 18.8
Senior Notes – 4.000%      
FINANCING ACTIVITIES      
Proceeds from Issuance of Senior Notes 500.0 0.0 0.0
Senior Notes – 4.375%      
FINANCING ACTIVITIES      
Proceeds from Issuance of Senior Notes 400.0 0.0 0.0
4.500% Senior Notes      
FINANCING ACTIVITIES      
Proceeds from Issuance of Senior Notes 0.0 450.0 0.0
6.000% Senior Notes      
FINANCING ACTIVITIES      
Repayment of Senior Notes $ 0.0 $ (400.0) $ 0.0